Prostate-specific antigen nadir of 0.5 ng/ml or less defines disease freedom for surgically staged men irradiated for prostate cancer-Reference-Cited by-同舟云学术

Prostate-specific antigen nadir of 0.5 ng/ml or less defines disease freedom for surgically staged men irradiated for prostate cancer

Published:1997-05 Issue:5 Volume:49 Page:668-672
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Critz Frank A.,Levinson Keith,Hamilton Williams W.,Holladay David,Holladay Clinton,Griffin Vivian

Publisher

Elsevier BV

Subject

Urology

Reference20 articles.

1. Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostate;Schellhammer;Urology,1993

2. Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostate cancer;Zelefsky;J Clin Urol,1995

3. Outcome for surgically staged localized prostate cancer treated with external beam radiation therapy (abstract);Powell;J Urol,1996

4. PSA confirmation of cure at 10 years of T1B,T2,N0,M0 prostate cancer patients treated in RTOG protocol 7706 with external beam irradiation;Hanks;Int J Radiat Oncol Biol Phys,1994

5. Failure of open radioactive 125 iodine implantation to control localized pros-tate cancer: a study of 41 patients;Gottesman;J Urol,1991

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survival;International Journal of Clinical Oncology;2018-06-22

2. Difference in the rate of rectal complications following prostate brachytherapy based on the prostate-rectum distance and the prostate longitudinal length among early prostate cancer patients;Korean Journal of Urology;2015

3. Identifying Differences Between Biochemical Failure and Cure: Incidence Rates and Predictors;International Journal of Radiation Oncology*Biology*Physics;2011-11

4. Rectum dose reduction and individual treatment plan optimization for high-dose-rate prostate brachytherapy;Brachytherapy;2007-10

5. Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure;Urology;2006-12